Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

U.S. Ureteral Access Sheath Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach USD 266.19 Million as Minimally Invasive Stone Care Drives 6.5% CAGR

globenewswire.com
BSX Boston Scientific Corporation is mentioned as a key player in the U.S. ureteral access sheath market, which is projected to grow significantly. The article does not provide specific sentiment towards the company itself, but its inclusion in a growing market is generally positive. BDX BD is listed as a key company in the U.S. ureteral access sheath market. The article focuses on market trends and growth, not specific company performance, thus the sentiment is neutral. COLB Coloplast is mentioned as a key company in the U.S. ureteral access sheath market. The article provides a market analysis and forecast, but no specific details about Coloplast's performance or outlook. COOK Cook Medical is listed as a key company in the U.S. ureteral access sheath market. The article discusses market growth drivers and trends, but does not offer specific sentiment or performance data for Cook Medical. APLD Applied Materials is mentioned as a key company in the U.S. ureteral access sheath market. The article focuses on market growth and trends, not on the specific performance or strategic direction of Applied Materials.

U.S. Ureteral Access Sheath Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach USD 266.19 Million as Minimally Invasive Stone Care Drives 6.5% CAGR Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "U.S. Ureteral Access Sheath Market Size, Share & Trends Analysis Report by Product Type, Clinical Indication, Age Group, Size, End-Use, and Growth Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering.

U.S. Ureteral Access Sheath Market to Reach USD 266.19 Million by 2033

The U.S. ureteral access sheath market was valued at an estimated USD 160.34 million in 2025 and is projected to reach USD 266.19 million by 2033, expanding at a compound annual growth rate of 6.5% from 2026 to 2033. Growth is being supported by the rising prevalence of urolithiasis and other urological disorders, increasing ureteroscopy volumes, and broader adoption of minimally invasive urological procedures.

Kidney stone disease represents a substantial clinical burden in the U.S. According to the National Kidney Foundation, more than 500,000 people visit emergency rooms each year because of kidney stones. Approximately 1 in 10 people experience a kidney stone during their lifetime, with the condition affecting about 11 out of every 100 men and 9 out of every 100 women. Lifestyle and dietary changes may contribute to continued growth in kidney stone incidence, generating sustained demand for stone management procedures and ureteral access devices.

Ureteroscopy, retrograde intrarenal surgery (RIRS), and laser lithotripsy are among the procedures supporting demand for ureteral access sheaths. These devices facilitate instrument exchanges and assist with intrarenal pressure control during treatment. The shift toward procedures associated with shorter hospital stays, fewer complications, and faster recovery is also encouraging adoption across hospitals, specialty clinics, ambulatory surgical centers, and other outpatient settings.

The AUA 2026 kidney stone surgery guideline is expected to further support market development by recommending ureteroscopy as a primary treatment option for many kidney and ureteral stones. The guideline permits the use of ureteral access sheaths, including advanced suction-based designs, during URS procedures. Combined with the high volume of stone surgeries performed in the U.S., these recommendations are expected to strengthen procedural demand for UAS devices.

Product innovation remains a central U.S. ureteral access sheath market trend. Advances in flexible materials, hydrophilic coatings, pressure-controlled technology, and dual-lumen designs are improving procedural safety, efficiency, and clinical outcomes. These technologies may reduce ureteral trauma, support optimal intrarenal pressure, and expand the use of access sheaths in complex minimally invasive procedures.

In August 2025, the Journal of the Formosan Medical Association highlighted the ongoing prevalence, economic burden, and high recurrence rate of urolithiasis. Advances in flexible ureteroscopes (fURS) and high-power holmium laser (HPHL) technologies have broadened treatment indications and supported the use of RIRS for complex upper urinary tract stones. Flexible and navigable suction (FANS) ureteral access sheaths (UAS) have also demonstrated effective intrarenal pressure control, high stone-free rates, and minimal serious adverse events. However, the increasing cost of disposable fURS and HPHL systems remains an important consideration for healthcare providers.

Strong healthcare infrastructure, favorable reimbursement policies, and continued migration toward outpatient urology procedures provide additional support for market expansion. Although higher costs associated with advanced disposable technologies may affect purchasing decisions, increasing procedure volumes and demand for improved clinical performance are expected to sustain investment in advanced ureteral access sheath products.

Market Segmentation

The report analyzes revenue growth and industry opportunities in the U.S. from 2021 to 2033. Market segmentation covers product type, size, age group, clinical indication, and end-use.

Product Type Outlook (Revenue, USD Million, 2021-2033)

Size Outlook (Revenue, USD Million, 2021-2033)

Age Group Outlook (Revenue, USD Million, 2021-2033)

Clinical Indication Outlook (Revenue, USD Million, 2021-2033)

End-use Outlook (Revenue, USD Million, 2021-2033)

Key Benefits of the Report

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope

1.2. Segment Definitions

1.2.1. Product Type

1.2.2. Size

1.2.3. Clinical Indication

1.2.4. Age Group

1.2.5. End Use

1.2.6. Estimates and forecasts timeline

1.3. Research Methodology

1.4. Information Procurement

1.4.1. Purchased database

1.4.2. Internal database

1.4.3. Secondary sources

1.4.4. Primary research

1.4.5. Details of primary research

1.5. Information or Data Analysis

1.5.1. Data analysis models

1.6. Market Formulation & Validation

1.7. Model Details

1.7.1. Commodity flow analysis (Model 1)

1.7.2. Approach 1: Commodity flow approach

1.7.3. Volume price analysis (Model 2)

1.7.4. Approach 2: Volume price analysis

1.8. List of Secondary Sources

1.9. List of Primary Sources

1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. U.S. Ureteral Access Sheath Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.2.3. Market Opportunity Analysis

3.2.4. Market Challenge Analysis

3.3. U.S. Ureteral Access Sheath Market Analysis Tools

3.3.1. Industry Analysis - Porter's

3.3.2. PESTEL Analysis

Chapter 4. U.S. Ureteral Access Sheath Market: Product Type Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. U.S. Ureteral Access Sheath Market: Product Type Movement Analysis

4.3. U.S. Ureteral Access Sheath Market by Product Type Outlook (USD Million)

4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

4.5. Standard (Single-Lumen)

4.5.1. Standard (Single-Lumen) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.6. Reinforced

4.6.1. Reinforced Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

4.7. Dual-Lumen

4.7.1. Dual-Lumen Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 5. U.S. Ureteral Access Sheath Market: Size Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. U.S. Ureteral Access Sheath Market: Size Movement Analysis

5.3. U.S. Ureteral Access Sheath Market by Size Outlook (USD Million)

5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

5.5. < 10

5.5.1. < 10 Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

5.6. 10 to 12

5.6.1. 10 to 12 Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

5.7. More than or equal to 13 - 15

5.7.1. More than or equal to 13 - 15 Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 6. U.S. Ureteral Access Sheath Market: Age Group Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. U.S. Ureteral Access Sheath Market: Age Group Movement Analysis

6.3. U.S. Ureteral Access Sheath Market by Age Group Outlook (USD Million)

6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

6.5. Adult

6.5.1. Adult Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

6.6. Pediatric

6.6.1. Pediatric Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 7. U.S. Ureteral Access Sheath Market: Clinical Indication Estimates & Trend Analysis

7.1. Segment Dashboard

7.2. U.S. Ureteral Access Sheath Market: Clinical Indication Movement Analysis

7.3. U.S. Ureteral Access Sheath Market by Clinical Indication Outlook (USD Million)

7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

7.5. Stone Management

7.5.1. Stone Management Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

7.6. Others

7.6.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 8. U.S. Ureteral Access Sheath Market: End Use Estimates & Trend Analysis

8.1. Segment Dashboard

8.2. U.S. Ureteral Access Sheath Market: End Use Movement Analysis

8.3. U.S. Ureteral Access Sheath Market by End Use Outlook (USD Million)

8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following

8.5. Hospitals

8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

8.6. Specialty Clinics

8.6.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

8.7. Diagnostic Centers

8.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

8.8. Ambulatory Surgery Centers (ASCs)

8.8.1. Ambulatory Surgery Centers (ASCs) Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

8.9. Others

8.9.1. Others Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization

9.2. Company Share Analysis, 2025

9.3. Key Company Profiles

9.3.1. Boston Scientific Corporation

9.3.2. BD

9.3.3. Olympus

9.3.4. Coloplast

9.3.5. Cook Medical

9.3.6. Advin Health Care

9.3.7. ACE Medical Devices

9.3.8. Blue Neem Medical Devices Private Limited

9.3.9. AMECATH

9.3.10. Applied Medical Resources Corporation

9.3.11. Volkmann Medizintechnik GmbH

9.3.12. Urovision-Urotech

9.3.13. Rocamed SAM

9.3.14. Well Lead Medical Co., Ltd.

9.3.15. Richard Wolf GmbH

9.3.16. SCW Medicath Ltd

List of Tables [7]

List of Figures [35]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/eg1inb

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.